Journal of Biochemistry Advance Access originally published online on May 28, 2008
Journal of Biochemistry 2008 144(3):313-321; doi:10.1093/jb/mvn068
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2008 The Japanese Biochemical Society
Krüppel-like Factor 4 is Required for the Expression of Vascular Smooth Muscle Cell Differentiation Marker Genes Induced by All-Trans Retinoic Acid
Department of Biochemistry and Molecular Biology, Hebei Medical University, Shijiazhuang 050017, China
*To whom correspondence should be addressed. Tel: +86 311 86266180, Fax: +86 311 86696826, E-mail: wjk{at}hebmu.edu.cn
Received February 16, 2008; Accepted May 2, 2008
| Abstract |
|---|
Krüppel-like factor 4 (KLF4) is involved in phenotypic modulation of vascular smooth muscle cells (VSMCs). All-trans retinoic acid (ATRA) inhibits VSMC proliferation and induces VSMC differentiation. However, the role of KLF4 in ATRA-elicited VSMC phenotypic modulation remains unclear. Here, we show that treatment of VSMCs with ATRA resulted in significant inhibition of proliferation and migration of VSMCs, as well as up-regulation of KLF4 and the VSMC differentiation marker genes SM22
and SM
-actin (
-SMA). At the same time, the KLF4 target gene p53 was up-regulated, while the VSMC dedifferentiation marker gene nonmuscle myosin heavy chain-B (SMemb) was down-regulated. We also show that overexpression of KLF4 in VSMCs increased the expression of p53, SM22
and
-SMA, but decreased the expression of SMemb and VSMC proliferation and migration. Silencing of KLF4 expression by KLF4-specific small interfering RNA (siRNA) abrogated the inducing effects of ATRA on p53, SM22
and
-SMA expression and neutralized the inhibitory effects of ATRA on SMemb expression and VSMC proliferation and migration. Thus, our data suggest that KLF4 is required for the expression of VSMC differentiation marker genes induced by ATRA and that this transcription factor is one of the key mediators of retinoid actions in VSMCs.
Key Words: all-trans retinoic acid, expression, KLF4, marker gene, VSMC
Abbreviations:
ATRA, all-trans retinoic acid;
-SMA, SM
-actin; DMEM, Dulbecco's modified Eagles medium; DMSO, dimethyl sulfoxide; KLF4, Krüppel-like factor 4; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl; SMemb, smooth muscle embryonic type myosin heavy chain-B; siRNA, small interfering RNA; VSMCs, vascular smooth muscle cells
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Xin, E. M. Small, L. B. Sutherland, X. Qi, J. McAnally, C. F. Plato, J. A. Richardson, R. Bassel-Duby, and E. N. Olson MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury Genes & Dev., September 15, 2009; 23(18): 2166 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zheng, M. Han, M. Bernier, X.-h. Zhang, F. Meng, S.-b. Miao, M. He, X.-m. Zhao, and J.-k. Wen Kruppel-like Factor 4 Inhibits Proliferation by Platelet-derived Growth Factor Receptor {beta}-mediated, Not by Retinoic Acid Receptor {alpha}-mediated, Phosphatidylinositol 3-Kinase and ERK Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., August 21, 2009; 284(34): 22773 - 22785. [Abstract] [Full Text] [PDF] |
||||

